To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene ITGAVTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
530 supporting clones for gene ITGAV back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AK302990 testis .a 1 to 2982 307 to 3288 V678I     2982/3288
(90 %)
1 diff
(100.0 %id)
AK309711   .a 1 to 1046 591 to 1636       1046/1896
(55 %)
5 diff
(99.8 %id)
BP202234 amygdala .a 1 to 432 151 to 582       432/582
(74 %)
0 diff
(100 %id)
BC126231 Pooled, cerebellum, kidney, placenta,testis, lung, colon, liver, heart, thyroid, bladder,uterus, PCR rescued clones .a 1 to 3912 444 to 4351 V678I tiling clone,   3908/4351
(89 %)
3 diff
(100.0 %id)
BC136442 Pooled, cerebellum, kidney, placenta,testis, lung, colon, liver, heart, thyroid, bladder,uterus, PCR rescued clones .a 1 to 3912 444 to 4355 V678I     3912/4355
(89 %)
1 diff
(100.0 %id)
TI_1520875621   .a 1 to 534 527 to 1061       535/1246
(42 %)
5 diff
(99.6 %id)
EF560727 colon endothelium, primary cell culture .a 1 to 2961 359 to 3319 V678I C747R     2961/3319
(89 %)
5 diff
(99.9 %id)
M14648   .a 1 to 5362 356 to 5717 V678I tiling clone,   5362/5717
(93 %)
5 diff
(100.0 %id)
NM_002210.3   .a 1 to 6441 591 to 7031 V678I RefSeq, AAA   6441/7031
(91 %)
1 diff
(100.0 %id)
NM_001144999.1   .a 1 to 6441 307 to 6747 V678I RefSeq, AAA   6441/6747
(95 %)
1 diff
(100.0 %id)
BP336881 coronary artery .a 1 to 379 218 to 596       379/596
(63 %)
0 diff
(100 %id)
DR004334 placenta .a 1 to 317 398 to 714       317/714
(44 %)
3 diff
(99.6 %id)
TI_1520873239   .a 39 to 1215 1176 to 10       1167/1227
(95 %)
23 diff
(98.2 %id)
AW582577 stomach .a 46 to 551 26 to 529       504/531
(94 %)
5 diff
(99.1 %id)
DN913730   .a 246 to 661 1 to 416       416/416
(100 %)
2 diff
(99.6 %id)
AB209894 aorta endothelial cell .b 1 to 6330 574 to 6898 V642I tiling clone,   6325/6898
(91 %)
5 diff
(100.0 %id)
BC144100 Pooled, cerebellum, kidney, placenta,testis, lung, colon, liver, heart, thyroid, bladder,uterus, PCR rescued clones .b 1 to 3804 444 to 4247 F559L V642I     3804/4247
(89 %)
2 diff
(100.0 %id)
TI_2194645256   .b 1 to 693 528 to 1208       681/1274
(53 %)
11 diff
(99.2 %id)
TI_2194646212   .b 1 to 534 530 to 1077       545/1088
(50 %)
20 diff
(98.2 %id)
TI_2194647007   .b 1 to 823 24 to 849       826/849
(97 %)
3 diff
(99.7 %id)
NM_001145000.1   .b 1 to 6333 591 to 6923 V642I RefSeq, AAA   6333/6923
(91 %)
1 diff
(100.0 %id)
BP358693 mammary gland .b 232 to 813 1 to 584       584/584
(100 %)
5 diff
(99.2 %id)
CN409392 embryonic stem cells, cell lines H1, H7, andH9 .b 298 to 951 1 to 653       653/653
(100 %)
2 diff
(99.7 %id)
TI_1520877443   .b 345 to 659 16 to 329       314/329
(95 %)
4 diff
(98.8 %id)
CN409415 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 379 to 977 1 to 601       601/601
(100 %)
3 diff
(99.6 %id)
BF841485 head_neck .b 388 to 877 12 to 502       491/506
(97 %)
11 diff
(97.9 %id)
DA448464 tongue, tumor tissue .b 433 to 972 2 to 541   capped   540/540
(100 %)
2 diff
(99.7 %id)
BP250578 hippocampus .b 503 to 1083 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
CN409410 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 512 to 1274 1 to 763       763/763
(100 %)
1 diff
(99.9 %id)
TI_1520872297   .b 552 to 994 1 to 442       442/442
(100 %)
7 diff
(98.5 %id)
AA421988 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 588 to 1146 1 to 558       558/558
(100 %)
1 diff
(99.9 %id)
AL707747 human skeletal muscle .b 684 to 1270 1 to 587       587/587
(100 %)
0 diff
(100 %id)
BF997767 placenta_normal .b 694 to 1200 518 to 11       508/518
(98 %)
5 diff
(99.1 %id)
BP231715 muscle .b 737 to 1317 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
BP231735 muscle .b 737 to 1318 1 to 581       581/581
(100 %)
2 diff
(99.7 %id)
TI_2194647011   .b 765 to 1854 1 to 1084       1082/1086
(99 %)
21 diff
(98.1 %id)
TI_2194647014   .b 1112 to 2118 1 to 1006       1006/1007
(99 %)
17 diff
(98.4 %id)
TI_1520877435   .b 1115 to 2257 1 to 1145       1146/1234
(92 %)
26 diff
(97.9 %id)
TI_1520873061   .b 1145 to 2017 886 to 7       886/966
(91 %)
11 diff
(98.9 %id)
CN409402 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 1192 to 1898 1 to 707       707/707
(100 %)
0 diff
(100 %id)
DA034499   .b 1236 to 1772 2 to 540   capped   539/539
(100 %)
3 diff
(99.5 %id)
CD614231   .b 1292 to 1757 1 to 467       467/467
(100 %)
6 diff
(98.8 %id)
CD614232   .b 1297 to 1783 503 to 16       488/508
(96 %)
1 diff
(99.9 %id)
TI_1520873215   .b 1307 to 2398 1115 to 25       1096/1245
(88 %)
16 diff
(98.8 %id)
CN409401 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 1394 to 1966 1 to 573       573/573
(100 %)
1 diff
(99.9 %id)
BM832854 stomach .b 1396 to 1976 1 to 581       581/581
(100 %)
2 diff
(99.7 %id)
TI_2194647003   .b 1401 to 2370 1 to 973       973/973
(100 %)
17 diff
(98.3 %id)
BX489380   .b 1530 to 2285 1 to 757       757/761
(99 %)
6 diff
(99.3 %id)
CN409396 embryonic stem cells, cell lines H1, H7, andH9 .b 1546 to 2237 1 to 693       693/693
(100 %)
5 diff
(99.3 %id)
CN409407 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 1581 to 2078 1 to 498       498/498
(100 %)
1 diff
(99.8 %id)
BE095175 breast .b 1710 to 1811 121 to 21     Submitted on the opposite strand 101/121
(83 %)
7 diff
(94.3 %id)
DB233410 trachea .b 1752 to 2331 2 to 581   capped   580/580
(100 %)
4 diff
(99.4 %id)
CN409387 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 1753 to 2298 1 to 546       546/546
(100 %)
1 diff
(99.9 %id)
BM550972 duodenal adenocarcinoma, cell line, small intestine .b 1790 to 2629 1 to 850       850/1140
(74 %)
18 diff
(98.5 %id)
CN409383 embryonic stem cells, cell lines H1, H7, andH9 .b 1798 to 2537 1 to 740       740/740
(100 %)
4 diff
(99.5 %id)
DB464280 hippocampus .b 1800 to 2265 1 to 465       465/465
(100 %)
6 diff
(98.8 %id)
DB471142 hippocampus .b 1800 to 2270 1 to 470       470/470
(100 %)
3 diff
(99.4 %id)
AA101791   .b 1826 to 2398 1 to 572       572/660
(86 %)
7 diff
(99.0 %id)
CN409408 embryonic stem cells, DMSO-treated H9 cellline .b 1856 to 2180 1 to 325       325/325
(100 %)
6 diff
(98.2 %id)
CA389302 eye, RPE/choroid .b 1862 to 2319 1 to 458       458/458
(100 %)
1 diff
(99.8 %id)
BF981079 duodenal adenocarcinoma, cell line, small intestine .b 1862 to 2566 1 to 707       705/711
(99 %)
11 diff
(98.5 %id)
BF667465 brain, primitive neuroectoderm .b 1889 to 2543 1 to 647       647/884
(73 %)
18 diff
(98.0 %id)
CN409391 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 1926 to 2662 1 to 736       736/736
(100 %)
1 diff
(99.9 %id)
CA396552 eye, RPE/choroid .b 1948 to 2522 1 to 575       575/575
(100 %)
0 diff
(100 %id)
CN409398 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 1956 to 2639 1 to 684       684/684
(100 %)
1 diff
(99.9 %id)
TI_1520877437   .b 1977 to 3146 1 to 1160       1160/1165
(99 %)
33 diff
(97.2 %id)
TI_2194647000   .b 1977 to 3097 1 to 1108       1108/1114
(99 %)
33 diff
(97.1 %id)
BM786564 Ascites, stomach .b 1981 to 2571 1 to 591       591/591
(100 %)
0 diff
(100 %id)
DA240399 brain .b 1982 to 2572 2 to 592   capped   591/591
(100 %)
3 diff
(99.5 %id)
BX481015   .b 2006 to 2397 1 to 392       392/392
(100 %)
0 diff
(100 %id)
DB220075 trachea .b 2110 to 2665 2 to 558   capped   557/557
(100 %)
2 diff
(99.7 %id)
TI_2194646996   .b 2206 to 3352 8 to 1148       1141/1165
(97 %)
36 diff
(97.0 %id)
BC047454 testis .b 2219 to 6333 1 to 4113   tiling clone, available from MGC, AAA   4113/4113
(100 %)
5 diff
(99.9 %id)
DB444261 testis .b 2220 to 2677 1 to 460       460/460
(100 %)
5 diff
(99.0 %id)
DB457952 testis .b 2220 to 2715 1 to 496       496/496
(100 %)
1 diff
(99.8 %id)
DA325231 hippocampus .b 2233 to 2786 2 to 556   capped   555/555
(100 %)
1 diff
(99.9 %id)
DA317890 hippocampus .b 2303 to 2842 2 to 541   capped   540/540
(100 %)
0 diff
(100 %id)
CN409405 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 2317 to 2632 1 to 316       316/316
(100 %)
2 diff
(99.4 %id)
DB227662 trachea .b 2384 to 2945 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
TI_1520873053   .b 2399 to 3322 925 to 2       924/966
(95 %)
6 diff
(99.4 %id)
DA322507 hippocampus .b 2417 to 2970 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
BX479168   .b 2456 to 2878 1 to 423       423/423
(100 %)
0 diff
(100 %id)
CB044029 colon, juvenile granulosa tumor .b 2488 to 3157 12 to 681       670/681
(98 %)
0 diff
(100 %id)
BE003533 breast_normal .b 2497 to 2643 23 to 171       149/171
(87 %)
0 diff
(100 %id)
DA192466 amygdala .b 2535 to 3078 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
CA389708 eye, RPE/choroid .b 2536 to 3182 1 to 647       647/647
(100 %)
0 diff
(100 %id)
BG819384 anaplastic oligodendroglioma with 1p/19qloss, brain .b 2559 to 3217 1 to 651       651/656
(99 %)
14 diff
(97.9 %id)
AA307350 colon .b 2569 to 2965 1 to 397       397/397
(100 %)
0 diff
(100 %id)
DA249578 brain .b 2571 to 3096 2 to 528   capped   527/527
(100 %)
1 diff
(99.9 %id)
DA245866 brain .b 2609 to 3182 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
BF983862 duodenal adenocarcinoma, cell line, small intestine .b 2625 to 3317 1 to 697       697/1051
(66 %)
23 diff
(97.9 %id)
TI_2194646219   .b 2637 to 3804 1283 to 117       1167/1300
(89 %)
0 diff
(100 %id)
TI_2194646997   .b 2638 to 3610 1 to 974       974/975
(99 %)
12 diff
(98.8 %id)
DA405362 thalamus .b 2638 to 3197 2 to 564   capped   563/563
(100 %)
4 diff
(99.3 %id)
DB287176 uterus .b 2640 to 3178 2 to 541   capped   540/540
(100 %)
1 diff
(99.9 %id)
TI_1520877439   .b 2650 to 3610 12 to 971       960/972
(98 %)
4 diff
(99.6 %id)
TI_2194645635   .b 2664 to 3804 1243 to 114       1130/1298
(87 %)
0 diff
(100 %id)
BG623902 placenta .b 2671 to 3037 1 to 367   AAA   367/367
(100 %)
0 diff
(100 %id)
BP390311 pancreatic islet .b 2672 to 3037 1 to 366     Submitted on the opposite strand 366/366
(100 %)
1 diff
(99.8 %id)
TI_1520875623   .b 2677 to 3811 1230 to 106       1125/1272
(88 %)
0 diff
(100 %id)
BM548689 duodenal adenocarcinoma, cell line, small intestine .b 2684 to 3558 1 to 889       889/1019
(87 %)
29 diff
(97.2 %id)
DB224388 trachea .b 2715 to 3257 2 to 546   capped   545/545
(100 %)
2 diff
(99.7 %id)
DA472422   .b 2735 to 3182 2 to 449   capped   448/448
(100 %)
1 diff
(99.8 %id)
DA103092 cerebellum .b 2741 to 3300 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DA211608 brain .b 2775 to 3249 2 to 477   capped   476/476
(100 %)
1 diff
(99.8 %id)
AL700009 human skeletal muscle .b 2793 to 3402 1 to 611       611/611
(100 %)
2 diff
(99.7 %id)
DA330327 hippocampus .b 2796 to 3334 2 to 541   capped   540/540
(100 %)
1 diff
(99.9 %id)
BX641614   .b 2799 to 3440 1 to 640       640/640
(100 %)
4 diff
(99.4 %id)
DA229470 brain .b 2802 to 3377 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
CN409397 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 2824 to 3235 1 to 413       413/413
(100 %)
6 diff
(98.6 %id)
BX498598 Liver .b 2843 to 3188 1 to 346       346/346
(100 %)
0 diff
(100 %id)
AA853870 Bone, Hip .b 2852 to 3160 1 to 309       309/309
(100 %)
0 diff
(100 %id)
DB222766 trachea .b 2853 to 3427 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DA121097 cerebellum .b 2865 to 3405 2 to 543   capped   542/542
(100 %)
1 diff
(99.9 %id)
DB236609 trachea .b 2938 to 3523 2 to 588   capped   587/587
(100 %)
1 diff
(99.9 %id)
DB141855 thymus .b 2969 to 3509 2 to 543   capped   542/542
(100 %)
1 diff
(99.9 %id)
CN409393 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 2990 to 3618 1 to 629       629/629
(100 %)
3 diff
(99.6 %id)
DA026336   .b 3004 to 3569 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
DA471945   .b 3010 to 3588 2 to 580   capped   579/579
(100 %)
1 diff
(99.9 %id)
DA171192 amygdala .b 3025 to 3591 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
BX499651 Liver .b 3039 to 3779 1 to 736       736/736
(100 %)
6 diff
(99.2 %id)
DB082627 testis .b 3054 to 3619 2 to 567   capped   566/566
(100 %)
1 diff
(99.9 %id)
DB141373 thymus .b 3066 to 3631 2 to 569   capped   568/568
(100 %)
2 diff
(99.7 %id)
DB139535 thymus .b 3075 to 3610 2 to 540   capped   539/539
(100 %)
3 diff
(99.5 %id)
DA805133 brain .b 3089 to 3646 2 to 559   capped   558/565
(98 %)
1 diff
(99.9 %id)
CA414700 Chondrosarcoma Grade II, Left Pelvis .b 3091 to 3820 2 to 729     Submitted on the opposite strand 728/729
(99 %)
0 diff
(100 %id)
BQ308612 breast .b 3097 to 3375 1 to 279       279/289
(96 %)
5 diff
(98.3 %id)
DA550096   .b 3105 to 3696 2 to 593   capped   592/592
(100 %)
0 diff
(100 %id)
BG939142 Bone, Hip .b 3110 to 3728 1 to 619       619/619
(100 %)
4 diff
(99.4 %id)
DA864254 placenta .b 3121 to 3610 2 to 495   capped   494/494
(100 %)
4 diff
(99.2 %id)
TI_1520877447   .b 3124 to 3811 1 to 684       684/1225
(55 %)
12 diff
(99.1 %id)
TI_2194647001   .b 3124 to 3804 1 to 680       680/1051
(64 %)
3 diff
(99.8 %id)
DB085009 testis .b 3141 to 3644 2 to 505   capped   504/504
(100 %)
0 diff
(100 %id)
DA995950 synovial membrane tissue from rheumatioidarthritis .b 3150 to 3686 2 to 534   capped   533/533
(100 %)
2 diff
(99.7 %id)
CN409386 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 3165 to 3463 1 to 299       299/299
(100 %)
6 diff
(98.0 %id)
DA882198   .b 3172 to 3730 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DA738649   .b 3211 to 3764 2 to 556   capped   555/555
(100 %)
1 diff
(99.9 %id)
BG023903 duodenal adenocarcinoma, cell line, small intestine .b 3225 to 4017 1 to 795       795/999
(79 %)
35 diff
(96.5 %id)
BP423932 small intestine .b 3227 to 3757 1 to 526     Submitted on the opposite strand 526/526
(100 %)
4 diff
(99.3 %id)
DA156474 amygdala .b 3231 to 3808 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
DA390153 thalamus .b 3231 to 3816 2 to 588   capped   587/587
(100 %)
1 diff
(99.9 %id)
DR421780 eye, Pterygium .b 3252 to 3900 1 to 645       645/645
(100 %)
8 diff
(98.8 %id)
DA881959   .b 3252 to 3802 2 to 553   capped   552/552
(100 %)
1 diff
(99.9 %id)
CN409382 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 3287 to 3829 1 to 543       543/543
(100 %)
0 diff
(100 %id)
DA989618 synovial membrane tissue from rheumatioidarthritis .b 3299 to 3857 2 to 556   capped   555/555
(100 %)
2 diff
(99.7 %id)
BX477489   .b 3309 to 3824 1 to 516       516/516
(100 %)
0 diff
(100 %id)
DA654942   .b 3314 to 3885 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
DA170727 amygdala .b 3399 to 3974 2 to 575   capped   574/574
(100 %)
3 diff
(99.5 %id)
AW890141 nervous_tumor .b 3425 to 3836 409 to 1       409/411
(99 %)
12 diff
(97.1 %id)
AW899434 nervous_normal .b 3425 to 3836 409 to 1       409/411
(99 %)
12 diff
(97.1 %id)
AU120159 whole embryo, mainly body .b 3481 to 4340 2 to 862   capped   861/866
(99 %)
15 diff
(98.3 %id)
BU194864 melanotic melanoma, skin .b 3487 to 4332 1 to 848       848/850
(99 %)
11 diff
(98.8 %id)
DA144123 amygdala .b 3489 to 4041 2 to 555   capped   554/554
(100 %)
1 diff
(99.9 %id)
CA390239 eye, RPE/choroid .b 3504 to 3838 1 to 331       331/331
(100 %)
2 diff
(99.4 %id)
DA567870   .b 3537 to 4079 2 to 545   capped   544/544
(100 %)
3 diff
(99.5 %id)
DA736912   .b 3590 to 4414 2 to 822   capped   821/824
(99 %)
6 diff
(99.3 %id)
CB044919 colon, juvenile granulosa tumor .b 3591 to 4256 12 to 677   tiling clone,   666/677
(98 %)
0 diff
(100 %id)
AU136592 placenta .b 3599 to 4207 2 to 613   capped   612/613
(99 %)
8 diff
(98.7 %id)
AU137550 placenta .b 3602 to 4302 2 to 709   capped   708/756
(93 %)
10 diff
(98.7 %id)
BQ229352 melanotic melanoma, skin .b 3614 to 4229 1 to 623       623/976
(63 %)
21 diff
(97.9 %id)
C75073   .b 3618 to 4064 11 to 453       443/456
(97 %)
3 diff
(99.4 %id)
AU133190   .b 3629 to 4490 2 to 873   capped   872/879
(99 %)
31 diff
(96.5 %id)
BG696377 skin .b 3675 to 4163 1 to 490       490/490
(100 %)
5 diff
(99.0 %id)
CN409414 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 3684 to 4351 1 to 668       668/668
(100 %)
1 diff
(99.9 %id)
DB161647 thymus .b 3695 to 4266 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA392808 thalamus .b 3696 to 4266 2 to 572   capped   571/571
(100 %)
2 diff
(99.7 %id)
DB466902 hippocampus .b 3715 to 4149 1 to 436       436/436
(100 %)
3 diff
(99.4 %id)
W17002 lung .b 3732 to 4082 1 to 355       355/355
(100 %)
6 diff
(98.4 %id)
BF343140 brain, glioblastoma with EGFR amplification .b 3734 to 4423 4 to 693       690/1109
(62 %)
6 diff
(99.5 %id)
TI_45209307   .b 3745 to 4517 71 to 836       766/843
(90 %)
16 diff
(98.2 %id)
AA853723 Bone, Hip .b 3745 to 4018 31 to 304       274/304
(90 %)
0 diff
(100 %id)
BI254646 cervical carcinoma cell line, cervix .b 3751 to 4590 1 to 842       842/842
(100 %)
36 diff
(95.8 %id)
BI596449 brain, hypothalamus .b 3757 to 4517 1 to 754       754/761
(99 %)
14 diff
(98.2 %id)
DA250170 caudate nucleus .b 3772 to 4340 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
AU134924 placenta .b 3826 to 4595 2 to 780   capped   779/929
(83 %)
16 diff
(98.3 %id)
CN409394 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 3877 to 4557 1 to 686       686/690
(99 %)
7 diff
(99.0 %id)
DA487647 brain .b 3900 to 4475 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DA602220   .b 3900 to 4452 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
BQ716739 sympathetic trunk .b 3940 to 4568 1 to 637       637/997
(63 %)
35 diff
(96.5 %id)
BE855411 brain, glioblastoma (pooled) .b 3947 to 4429 499 to 17       483/499
(96 %)
0 diff
(100 %id)
BG402910 bladder, transitional cell papilloma, cell line .b 3956 to 4801 1 to 832       832/914
(91 %)
22 diff
(97.6 %id)
AI919211 brain, glioblastoma (pooled) .b 3961 to 4429 489 to 21       469/489
(95 %)
0 diff
(100 %id)
BG288939 bladder, transitional cell papilloma, cell line .b 3994 to 4671 1 to 680       680/901
(75 %)
18 diff
(98.1 %id)
CB962576 Blood vessels - aorta, basilar and artery .b 4006 to 4745 1 to 741       741/741
(100 %)
3 diff
(99.6 %id)
W01388 multiple sclerosis lesions .b 4035 to 4536 1 to 498       498/563
(88 %)
14 diff
(97.6 %id)
BF983036 duodenal adenocarcinoma, cell line, small intestine .b 4036 to 4764 1 to 735       735/896
(82 %)
22 diff
(97.6 %id)
TI_57221594   .b 4039 to 4775 60 to 790       731/800
(91 %)
16 diff
(98.0 %id)
BI757287 brain .b 4041 to 4775 1 to 729       729/739
(98 %)
14 diff
(98.2 %id)
DA148550 amygdala .b 4065 to 4633 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
DA751215   .b 4083 to 4654 2 to 575   capped   574/574
(100 %)
3 diff
(99.5 %id)
BF983046 duodenal adenocarcinoma, cell line, small intestine .b 4097 to 4763 1 to 669       669/1104
(60 %)
7 diff
(99.4 %id)
BE178607 head_neck .b 4101 to 4462 24 to 384       361/388
(93 %)
4 diff
(99.0 %id)
CD356337 Blood vessels - aorta, basilar and artery .b 4106 to 4814 1 to 718       718/718
(100 %)
25 diff
(96.6 %id)
T29242 adrenal gland, Bone .b 4118 to 4386 1 to 269       269/269
(100 %)
0 diff
(100 %id)
CN409411 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 4156 to 4642 1 to 487       487/487
(100 %)
0 diff
(100 %id)
DA275004 corpus callosum .b 4164 to 4737 2 to 576   capped   575/575
(100 %)
1 diff
(99.9 %id)
BX502387 Liver .b 4181 to 4470 1 to 300       300/300
(100 %)
15 diff
(95.0 %id)
BI868463 adenocarcinoma, cell line, Liver .b 4186 to 4816 1 to 635       635/709
(89 %)
14 diff
(98.1 %id)
TI_57228125   .b 4186 to 4816 54 to 688       635/709
(89 %)
14 diff
(98.1 %id)
BP275204 Kidney .b 4186 to 4765 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
BG819903 anaplastic oligodendroglioma with 1p/19qloss, brain .b 4193 to 4840 4 to 645       642/645
(99 %)
0 diff
(100 %id)
CN409404 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 4237 to 4877 1 to 641       641/641
(100 %)
1 diff
(99.9 %id)
DA598186   .b 4245 to 4804 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
BG168423 hypernephroma, cell line, Kidney .b 4253 to 5038 1 to 774       774/858
(90 %)
32 diff
(96.3 %id)
BG291864 bladder, transitional cell papilloma, cell line .b 4266 to 4890 1 to 624       624/624
(100 %)
2 diff
(99.7 %id)
BP289270 lung .b 4274 to 4843 1 to 574       574/584
(98 %)
3 diff
(99.5 %id)
DA750859   .b 4274 to 4837 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
CN409395 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 4291 to 5012 12 to 733       722/733
(98 %)
0 diff
(100 %id)
DA376933 thalamus .b 4292 to 4839 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
DA282497 corpus callosum .b 4322 to 4890 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
BP260278 heart .b 4322 to 4888 1 to 567       567/567
(100 %)
0 diff
(100 %id)
DA380286 thalamus .b 4332 to 4881 2 to 552   capped   551/551
(100 %)
1 diff
(99.9 %id)
AU118713 whole embryo, mainly head .b 4336 to 5097 2 to 762   capped   761/761
(100 %)
3 diff
(99.7 %id)
AU138662 placenta .b 4342 to 4967 2 to 628   capped   627/627
(100 %)
2 diff
(99.7 %id)
BI087340 cervix .b 4348 to 5044 1 to 714       714/768
(92 %)
31 diff
(96.0 %id)
CN409417 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 4359 to 5066 9 to 714       706/714
(98 %)
0 diff
(100 %id)
DB114710 thymus .b 4363 to 4917 2 to 556   capped   555/555
(100 %)
1 diff
(99.9 %id)
BF085172 placenta_normal .b 4377 to 4574 205 to 8       198/210
(94 %)
0 diff
(100 %id)
DA352430 substantia nigra .b 4386 to 4960 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
BM930820 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 4393 to 4959 1 to 566       566/566
(100 %)
6 diff
(99.0 %id)
TI_151789408   .b 4393 to 5157 79 to 842       764/938
(81 %)
26 diff
(97.3 %id)
R38118 placenta .b 4397 to 4757 1 to 373       373/377
(98 %)
24 diff
(93.7 %id)
BM016333 breast, mammary adenocarcinoma, cell line .b 4456 to 5171 1 to 715       715/715
(100 %)
8 diff
(98.9 %id)
TI_59394746   .b 4456 to 5171 86 to 800       715/715
(100 %)
8 diff
(98.9 %id)
TI_149295962   .b 4500 to 5395 966 to 81   AAA   886/975
(90 %)
22 diff
(97.8 %id)
BU164806 epithelioid carcinoma, Pancreas .b 4501 to 5294 1 to 810       810/890
(91 %)
27 diff
(97.0 %id)
BI333072 cervical carcinoma cell line, cervix .b 4525 to 5303 1 to 779       779/779
(100 %)
10 diff
(98.8 %id)
CR738464 uterus .b 4534 to 5206 1 to 674       674/674
(100 %)
1 diff
(99.9 %id)
AA030046 uterus .b 4534 to 4984 1 to 451       451/451
(100 %)
0 diff
(100 %id)
AA424624 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 4535 to 5080 1 to 545       545/545
(100 %)
18 diff
(96.7 %id)
AL541353 placenta .b 4553 to 5546 1 to 984       984/1010
(97 %)
22 diff
(97.9 %id)
CN409399 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 4564 to 5248 1 to 685       685/685
(100 %)
3 diff
(99.6 %id)
AV704335 adrenal gland .b 4589 to 5283 1 to 693       693/704
(98 %)
9 diff
(98.8 %id)
BF376181 testis_normal .b 4634 to 4995 1 to 356       356/356
(100 %)
8 diff
(97.8 %id)
BG287520 bladder, transitional cell papilloma, cell line .b 4637 to 5312 1 to 672       672/925
(72 %)
18 diff
(98.1 %id)
DA159932 amygdala .b 4653 to 5233 2 to 581   capped   580/580
(100 %)
2 diff
(99.7 %id)
BG260875 bladder, transitional cell papilloma, cell line .b 4660 to 5189 1 to 538       538/548
(98 %)
22 diff
(96.0 %id)
BG740031 skin .b 4672 to 5440 1 to 757       757/757
(100 %)
11 diff
(98.6 %id)
FN170456 breast carcinoma .b 4682 to 4786 105 to 1     Submitted on the opposite strand 105/105
(100 %)
2 diff
(98.1 %id)
CN409388 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 4700 to 5437 9 to 746       738/746
(98 %)
0 diff
(100 %id)
CN409409 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 4710 to 5154 1 to 446       446/446
(100 %)
5 diff
(98.9 %id)
BU684029 lung, Primary Lung Cystic Fibrosis EpithelialCells .b 4727 to 5395 687 to 19   AAA   669/669
(100 %)
1 diff
(99.9 %id)
FN087999 breast carcinoma .b 4746 to 4849 1 to 103       103/108
(95 %)
4 diff
(96.3 %id)
FN108825 breast carcinoma .b 4746 to 4854 1 to 109       109/109
(100 %)
2 diff
(98.2 %id)
AU120111 whole embryo, mainly head .b 4750 to 5500 2 to 752   capped   751/782
(96 %)
3 diff
(99.7 %id)
BE788768 large cell carcinoma, lung .b 4786 to 5471 1 to 671       671/935
(71 %)
25 diff
(97.4 %id)
CN409406 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 4791 to 5549 1 to 759   tiling clone,   759/759
(100 %)
0 diff
(100 %id)
W58556 heart .b 4813 to 5286 1 to 485       485/494
(98 %)
16 diff
(96.8 %id)
DB376834 placenta .b 5160 to 5667 503 to 1       503/504
(99 %)
18 diff
(96.5 %id)
CB044028 colon, juvenile granulosa tumor .b 5682 to 6333 668 to 17   AAA   652/652
(100 %)
0 diff
(100 %id)
DB356898 whole embryo, mainly head .b 5759 to 6330 573 to 1       573/576
(99 %)
9 diff
(98.5 %id)
DB358725 whole embryo, mainly head .b 5767 to 6330 562 to 1       562/563
(99 %)
22 diff
(96.1 %id)
DB370169   .b 5796 to 6333 538 to 1       538/538
(100 %)
9 diff
(98.4 %id)
DB358783 whole embryo, mainly body .b 5802 to 6333 532 to 1       532/537
(99 %)
12 diff
(97.8 %id)
W58557 heart .b 5805 to 6334 524 to 1       524/530
(98 %)
22 diff
(95.9 %id)
CB044918 colon, juvenile granulosa tumor .b 5832 to 6330 515 to 17   AAA   499/499
(100 %)
0 diff
(100 %id)
DB369484   .b 5834 to 6330 495 to 1       495/495
(100 %)
14 diff
(97.2 %id)
DB378581 placenta .b 5838 to 6335 500 to 1       500/500
(100 %)
7 diff
(98.6 %id)
DB372778 placenta .b 5874 to 6330 456 to 1       456/508
(89 %)
15 diff
(97.1 %id)
AA098978   .b 5907 to 6330 445 to 22   AAA   424/424
(100 %)
4 diff
(99.1 %id)
AA029934 uterus .b 5912 to 6330 441 to 14   AAA   428/464
(92 %)
13 diff
(97.2 %id)
AA424553 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 5961 to 6330 370 to 1       370/370
(100 %)
0 diff
(100 %id)
N62910 multiple sclerosis lesions .b 6116 to 6333 220 to 2       219/222
(98 %)
0 diff
(100 %id)
R38032 placenta .b 6224 to 6303 80 to 1       80/80
(100 %)
0 diff
(100 %id)
BX093445 Prostate .c 1 to 480 1 to 480   tiling clone,   480/480
(100 %)
1 diff
(99.8 %id)
AI659552 Prostate .c 245 to 980 782 to 47   tiling clone,   736/782
(94 %)
9 diff
(98.9 %id)
FN153499 breast carcinoma .c 554 to 651 1 to 95   tiling clone,   95/100
(95 %)
8 diff
(92.0 %id)
CK005265 brain/CNS, Human Brain - Frontal Cortex .c 638 to 1257 1 to 620   tiling clone,   620/620
(100 %)
4 diff
(99.4 %id)
BX484062   .c 887 to 1445 1 to 558   tiling clone,   558/558
(100 %)
0 diff
(100 %id)
DB292119 uterus .c 1151 to 1671 2 to 523   tiling clone, capped   522/522
(100 %)
3 diff
(99.5 %id)
AI433997 adenocarcinoma, Pancreas .c 1311 to 1670 361 to 1   tiling clone,   361/361
(100 %)
1 diff
(99.8 %id)
BM765455 stomach .d 1 to 640 1 to 640 V177I tiling clone,   640/640
(100 %)
2 diff
(99.7 %id)
AI765471 2 pooled tumors (clear cell type), Kidney .d 237 to 860 626 to 3   tiling clone,   624/626
(99 %)
0 diff
(100 %id)
DN913731   .d 629 to 878 251 to 2   tiling clone,   250/251
(99 %)
0 diff
(100 %id)
BQ129208.
matches multiple genes
Islets of Langerhans, Pancreas .e 1 to 544 557 to 14 exact tiling clone, AAA also hits gene mumemo 544/545
(99 %)
1 diff
(99.9 %id)
BQ880531 dorsal root ganglia .f-u 1 to 935 31 to 969 exact     943/969
(97 %)
0 diff
(100 %id)
AU117988 whole embryo, mainly head .f-u 1 to 845 2 to 849 T7P Y8M V9C Q10S P11H ... tiling clone, capped   848/851
(99 %)
16 diff
(98.2 %id)
BM700537 eye, lens .f-u 3 to 478 1 to 475       475/475
(100 %)
3 diff
(99.4 %id)
BM712020 eye, lens .f-u 3 to 562 1 to 559       559/559
(100 %)
4 diff
(99.3 %id)
CN409389 embryonic stem cells, cell lines H1, H7, andH9 .f-u 15 to 583 1 to 569       569/569
(100 %)
2 diff
(99.7 %id)
BM829561 Ascites, stomach .f-u 38 to 598 1 to 561       561/561
(100 %)
0 diff
(100 %id)
CN409385 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .f-u 46 to 457 1 to 412       412/412
(100 %)
1 diff
(99.8 %id)
CN409413 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .f-u 77 to 779 13 to 715       703/715
(98 %)
0 diff
(100 %id)
BG286953 bladder, transitional cell papilloma, cell line .f-u 77 to 755 16 to 693       678/1118
(60 %)
8 diff
(99.3 %id)
CN409416 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .f-u 86 to 630 1 to 545       545/545
(100 %)
0 diff
(100 %id)
DT220525 brain .f-u 87 to 748 1 to 662       662/662
(100 %)
0 diff
(100 %id)
BQ084573 stomach .f-u 95 to 425 1 to 331       331/331
(100 %)
2 diff
(99.4 %id)
BG400838 Kidney .f-u 105 to 879 1 to 774 S4L W5G N6I T7P Y8M ...     774/789
(98 %)
34 diff
(95.7 %id)
BP223715 colon mucosa .f-u 115 to 779 1 to 668       668/778
(85 %)
15 diff
(98.1 %id)
AI362407 Kidney, renal cell tumor .f-u 116 to 501 411 to 26   AAA   386/386
(100 %)
9 diff
(97.7 %id)
BF031684 hypernephroma, Kidney .f-u 131 to 757 1 to 623       623/807
(77 %)
17 diff
(97.9 %id)
BX089463 breast .f-u 168 to 851 1 to 684 exact     684/684
(100 %)
2 diff
(99.8 %id)
H44670 breast .f-u 168 to 478 1 to 312       312/313
(99 %)
8 diff
(97.5 %id)
BM788099 stomach .f-u 203 to 768 1 to 566       566/566
(100 %)
1 diff
(99.9 %id)
BP425944 small intestine .f-u 212 to 754 1 to 544     Submitted on the opposite strand 544/545
(99 %)
6 diff
(98.9 %id)
CR745996 multiple sclerosis lesions .f-u 248 to 1011 1 to 764 exact tiling clone,   764/768
(99 %)
4 diff
(99.5 %id)
N79133 multiple sclerosis lesions .f-u 258 to 469 1 to 212       212/221
(95 %)
1 diff
(99.6 %id)
AW297985   .f-u 268 to 731 61 to 523     Submitted on the opposite strand 463/523
(88 %)
0 diff
(100 %id)
BG740899 skin .f-u 291 to 976 1 to 687 exact     687/687
(100 %)
1 diff
(99.9 %id)
DT220931 brain .f-u 301 to 992 1 to 691 exact     691/691
(100 %)
2 diff
(99.8 %id)
AA344160 gall bladder .f-u 311 to 595 1 to 287       287/287
(100 %)
4 diff
(98.7 %id)
BF104912 Kidney .f-u 314 to 988 1 to 668 P11H L12H P13H I14L S15N ...     668/870
(76 %)
38 diff
(95.7 %id)
BX431371 placenta .f-u 322 to 1231 1 to 909 exact     909/989
(91 %)
22 diff
(97.8 %id)
BG290749 bladder, transitional cell papilloma, cell line .f-u 324 to 974 1 to 649 exact     649/650
(99 %)
3 diff
(99.6 %id)
W39067 parathyroid gland, parathyroid tumor .f-u 333 to 580 1 to 250       250/250
(100 %)
5 diff
(98.0 %id)
CB987725 Pooled-Glandular .f-u 341 to 1087 1 to 759 exact     759/882
(86 %)
22 diff
(97.6 %id)
AW793510 uterus .f-u 348 to 772 427 to 1       427/427
(100 %)
18 diff
(95.8 %id)
BE070064 breast .f-u 348 to 784 442 to 6     Submitted on the opposite strand 437/442
(98 %)
0 diff
(100 %id)
BE070090 breast .f-u 348 to 768 490 to 70     Submitted on the opposite strand 421/490
(85 %)
0 diff
(100 %id)
BG289188 bladder, transitional cell papilloma, cell line .f-u 353 to 1096 1 to 749 exact     749/984
(76 %)
27 diff
(97.3 %id)
BG546197 lung .f-u 357 to 1037 1 to 679 exact     679/679
(100 %)
4 diff
(99.5 %id)
BG260819 bladder, transitional cell papilloma, cell line .f-u 372 to 1082 1 to 704 exact     704/974
(72 %)
13 diff
(98.7 %id)
FN092684 breast carcinoma .f-u 393 to 509 119 to 1     Submitted on the opposite strand 119/119
(100 %)
2 diff
(98.4 %id)
CN409390 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .f-u 405 to 1131 1 to 728 exact     728/728
(100 %)
1 diff
(99.9 %id)
C02880 heart .f-u 408 to 776 1 to 370       370/370
(100 %)
6 diff
(98.4 %id)
CB162562 Liver .f-u 408 to 1024 1 to 616 exact     616/616
(100 %)
1 diff
(99.9 %id)
BM728668 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .f-u 408 to 1123 1 to 716 exact     716/716
(100 %)
0 diff
(100 %id)
BE185255 head_neck .f-u 412 to 770 15 to 373       359/373
(96 %)
0 diff
(100 %id)
AI146707 uterus .f-u 421 to 774 354 to 1       354/354
(100 %)
0 diff
(100 %id)
BF671931 muscle (skeletal) .f-u 428 to 1076 1 to 645 H21Y     645/650
(99 %)
8 diff
(98.8 %id)
BE017997 cervical carcinoma cell line, cervix .f-u 444 to 966 1 to 523 exact     523/523
(100 %)
0 diff
(100 %id)
W37188 parathyroid gland, parathyroid tumor .f-u 448 to 868 1 to 424 exact     424/427
(99 %)
4 diff
(99.1 %id)
FN113901 breast carcinoma .f-u 449 to 523 1 to 75       75/81
(92 %)
3 diff
(96.3 %id)
BE176669 head_neck .f-u 473 to 1161 682 to 1 exact   Submitted on the opposite strand 682/683
(99 %)
13 diff
(98.1 %id)
CN409412 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .f-u 474 to 1183 1 to 710 exact     710/710
(100 %)
0 diff
(100 %id)
AW362769 colon .f-u 482 to 637 158 to 2       157/158
(99 %)
0 diff
(100 %id)
BM311141 Pancreas, Purified pancreatic islet .f-u 484 to 1025 11 to 552 exact     542/552
(98 %)
0 diff
(100 %id)
BG291914 bladder, transitional cell papilloma, cell line .f-u 489 to 1199 1 to 703 exact     703/711
(98 %)
14 diff
(98.1 %id)
BG292091 bladder, transitional cell papilloma, cell line .f-u 490 to 1147 1 to 670 P11T I24H A25S C26Y I27V ...     670/1018
(65 %)
49 diff
(95.2 %id)
FN125777 breast carcinoma .f-u 517 to 622 106 to 1     Submitted on the opposite strand 106/106
(100 %)
0 diff
(100 %id)
T90615 lung .f-u 546 to 854 1 to 312 exact     312/317
(98 %)
5 diff
(98.5 %id)
BQ893540 dorsal root ganglia .f-u 548 to 1409 1 to 868 exact     868/913
(95 %)
15 diff
(98.4 %id)
BG108728 retina, Retinal Pigment Epithelium sheets .f-u 555 to 757 1 to 203       203/220
(92 %)
5 diff
(97.8 %id)
TI_154088320   .f-u 555 to 1116 637 to 76 exact     562/638
(88 %)
0 diff
(100 %id)
AA313002 Bone .f-u 562 to 864 1 to 306 exact     306/306
(100 %)
4 diff
(98.7 %id)
FN080811 breast carcinoma .f-u 562 to 642 82 to 1     Submitted on the opposite strand 82/83
(98 %)
1 diff
(98.8 %id)
TI_149290837   .f-u 568 to 1436 954 to 94 S2L R3D S4T W5X N6C ... AAA   861/981
(87 %)
26 diff
(97.4 %id)
FN056698 breast carcinoma .f-u 570 to 669 100 to 1     Submitted on the opposite strand 100/100
(100 %)
0 diff
(100 %id)
AA878573 2 pooled tumors (clear cell type), Kidney .f-u 570 to 1023 455 to 1 exact     455/455
(100 %)
4 diff
(99.2 %id)
FN094815 breast carcinoma .f-u 572 to 633 60 to 1     Submitted on the opposite strand 60/61
(98 %)
2 diff
(96.8 %id)
TI_154110236   .f-u 575 to 1436 928 to 71 L20X L31X L35* AAA   858/969
(88 %)
10 diff
(99.0 %id)
FN142321 breast carcinoma .f-u 581 to 648 1 to 68       68/69
(98 %)
1 diff
(98.6 %id)
H00966 placenta .f-u 581 to 916 1 to 340 exact     340/499
(68 %)
9 diff
(98.2 %id)
BG621708 placenta .f-u 582 to 1277 1 to 696 exact     696/735
(94 %)
9 diff
(98.8 %id)
BM830329 stomach .f-u 582 to 1177 1 to 596 exact     596/596
(100 %)
1 diff
(99.9 %id)
BM830330 stomach .f-u 582 to 1124 1 to 542 exact     542/542
(100 %)
1 diff
(99.9 %id)
BM830812 stomach .f-u 582 to 1102 1 to 521 exact     521/521
(100 %)
0 diff
(100 %id)
R78744 placenta .f-u 586 to 1064 1 to 467 exact fully sequenced,   467/467
(100 %)
20 diff
(95.8 %id)
FN083035 breast carcinoma .f-u 594 to 680 95 to 6     Submitted on the opposite strand 90/96
(93 %)
0 diff
(100 %id)
TI_154110245   .f-u 595 to 1436 902 to 71 S2G R3I S4P W5M N6C ... AAA   832/954
(87 %)
9 diff
(99.1 %id)
AW955553   .f-u 597 to 935 1 to 338 L35F K36T     338/338
(100 %)
16 diff
(95.3 %id)
TI_154110235   .f-u 612 to 1436 878 to 65 S2W R3I S4P W5M N6S ... AAA   814/937
(86 %)
16 diff
(98.3 %id)
BE768771 prostate_tumor .f-u 628 to 900 1 to 274 P11S S15Y M16N S17V P18T ...     274/274
(100 %)
6 diff
(97.9 %id)
FN051304 breast carcinoma .f-u 629 to 703 75 to 1     Submitted on the opposite strand 75/76
(98 %)
0 diff
(100 %id)
FN111374 breast carcinoma .f-u 642 to 729 88 to 1     Submitted on the opposite strand 88/92
(95 %)
2 diff
(97.9 %id)
AA044703 uterus .f-u 646 to 1229 1 to 584 exact     584/639
(91 %)
2 diff
(99.7 %id)
BI481246 Native Retinal Pigment Epithelium sheets, retina .f-u 650 to 1032 12 to 405 L12P P13T I14H S15L M16N ...     394/405
(97 %)
0 diff
(100 %id)
BU942899 mixed (pool of 40 RNAs) .f-u 652 to 1423 1 to 776 exact     776/781
(99 %)
11 diff
(98.6 %id)
CU456850 epidermis .f-u 658 to 911 1 to 254 exact     254/264
(96 %)
5 diff
(98.2 %id)
BE172026 head_neck .f-u 660 to 1221 1 to 563 S4L W5G N6I T7P Y8M ...     563/563
(100 %)
56 diff
(90.1 %id)
TI_149292470   .f-u 666 to 1436 858 to 88 S4X W5L N6D Q10S P11H ... AAA   771/889
(86 %)
7 diff
(99.3 %id)
BM693628 eye, fetal eyes .f-u 666 to 1284 1 to 619 exact     619/619
(100 %)
1 diff
(99.9 %id)
CD676605 eye, Trabecular meshwork .f-u 675 to 1269 1 to 595       595/595
(100 %)
0 diff
(100 %id)
AW385488 leiomios .f-u 687 to 878 1 to 191       191/191
(100 %)
8 diff
(95.9 %id)
BG109850 Bone, osteosarcoma, cell line .f-u 705 to 1341 1 to 636       636/907
(70 %)
10 diff
(98.9 %id)
BE708103 head_neck .f-u 714 to 877 176 to 13       164/176
(93 %)
0 diff
(100 %id)
AW576780 breast_normal .f-u 718 to 873 159 to 4       156/159
(98 %)
0 diff
(100 %id)
TI_149282081   .f-u 719 to 1436 806 to 89   AAA   718/719
(99 %)
5 diff
(99.4 %id)
AW576771 breast_normal .f-u 723 to 873 1 to 148       148/148
(100 %)
10 diff
(93.3 %id)
BF981617 duodenal adenocarcinoma, cell line, small intestine .f-u 725 to 1426 88 to 777       690/937
(73 %)
35 diff
(96.3 %id)
BU682417 lung .f-u 730 to 1436 726 to 19   AAA   708/708
(100 %)
1 diff
(99.9 %id)
BU629798 cell lines, Chondrosarcoma .f-u 730 to 1436 723 to 19   AAA   705/705
(100 %)
3 diff
(99.6 %id)
BG939141 Bone, Hip .f-u 741 to 1395 663 to 9       655/663
(98 %)
0 diff
(100 %id)
BE170674 head_neck .f-u 746 to 1173 27 to 453       427/453
(94 %)
0 diff
(100 %id)
TI_149283950   .f-u 750 to 1436 771 to 85   AAA   687/687
(100 %)
0 diff
(100 %id)
BG570796 placenta .f-u 753 to 1435 1 to 688       688/860
(80 %)
7 diff
(99.2 %id)
CB124575 Liver .f-u 761 to 1283 1 to 523       523/523
(100 %)
2 diff
(99.7 %id)
CB126727 Liver .f-u 761 to 1213 1 to 454       454/454
(100 %)
1 diff
(99.8 %id)
CB125854 Liver .f-u 761 to 1306 1 to 546       546/546
(100 %)
3 diff
(99.5 %id)
CB125876 Liver .f-u 761 to 1282 1 to 522       522/522
(100 %)
3 diff
(99.5 %id)
CN409403 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .f-u 763 to 1436 1 to 674   AAA   674/674
(100 %)
0 diff
(100 %id)
BE878396 large cell carcinoma, undifferentiated, lung .f-u 767 to 1440 1 to 682       682/694
(98 %)
23 diff
(96.7 %id)
AA095243   .f-u 770 to 1002 1 to 231       231/237
(97 %)
10 diff
(95.8 %id)
N56250   .f-u 770 to 934 1 to 165       165/165
(100 %)
8 diff
(95.2 %id)
AW068423 Bone, Hip .f-u 772 to 1397 645 to 8       638/646
(98 %)
0 diff
(100 %id)
BI438407 Pancreas, Purified pancreatic islet .f-u 774 to 1217 1 to 444       444/444
(100 %)
8 diff
(98.2 %id)
BM984332 lung .f-u 774 to 1436 681 to 19   AAA   663/666
(99 %)
0 diff
(100 %id)
TI_149308232   .f-u 777 to 1436 753 to 94   AAA   660/940
(70 %)
0 diff
(100 %id)
TI_149306507   .f-u 781 to 1439 760 to 102   AAA   659/906
(72 %)
4 diff
(99.6 %id)
BU686450 lung, Primary Lung Epithelial Cells .f-u 790 to 1439 669 to 20   AAA   650/650
(100 %)
0 diff
(100 %id)
BQ025424 placenta .f-u 791 to 1436 663 to 19   AAA   645/645
(100 %)
2 diff
(99.7 %id)
BU632661 cell lines, Chondrosarcoma .f-u 795 to 1436 660 to 19   AAA   642/650
(98 %)
1 diff
(99.9 %id)
BQ774298 Chondrosarcoma Grade II, Left Pelvis .f-u 797 to 1436 659 to 19   AAA   641/641
(100 %)
2 diff
(99.7 %id)
BC072686 Skin, melanotic melanoma. .f-u 799 to 1436 1 to 638   available from MGC, AAA   638/638
(100 %)
0 diff
(100 %id)
BU172094 melanotic melanoma, skin .f-u 800 to 1348 1 to 553   available from MGC,   553/1176
(47 %)
14 diff
(98.9 %id)
FN082840 breast carcinoma .f-u 802 to 909 109 to 1     Submitted on the opposite strand 109/115
(94 %)
1 diff
(99.2 %id)
BQ002676 Chondrosarcoma, Left Pelvis .f-u 808 to 1436 647 to 19   AAA   629/629
(100 %)
0 diff
(100 %id)
D45679 lung .f-u 811 to 930 1 to 120     Submitted on the opposite strand 120/129
(93 %)
3 diff
(97.7 %id)
BQ024732 placenta .f-u 814 to 1436 641 to 19   AAA   623/631
(98 %)
0 diff
(100 %id)
BQ024759 placenta .f-u 814 to 1436 641 to 19   AAA   623/635
(98 %)
0 diff
(100 %id)
FN136645 breast carcinoma .f-u 815 to 916 1 to 96       96/98
(97 %)
7 diff
(92.9 %id)
TI_149279701   .f-u 816 to 1436 679 to 58   AAA   622/1125
(55 %)
5 diff
(99.6 %id)
CB854429 lung, Primary Lung Epithelial Cells .f-u 816 to 1436 640 to 19   AAA   622/624
(99 %)
5 diff
(99.2 %id)
BG115103 duodenal adenocarcinoma, cell line, small intestine .f-u 817 to 1441 31 to 652       622/945
(65 %)
12 diff
(98.8 %id)
EB361616 eye, lens .f-u 827 to 1000 173 to 1       173/173
(100 %)
3 diff
(98.3 %id)
BE082479 breast .f-u 839 to 1427 589 to 1     Submitted on the opposite strand 589/589
(100 %)
1 diff
(99.9 %id)
BU934396 mixed (pool of 40 RNAs) .f-u 846 to 1440 1 to 596       596/601
(99 %)
3 diff
(99.6 %id)
FN126504 breast carcinoma .f-u 849 to 940 94 to 4     Submitted on the opposite strand 91/98
(92 %)
0 diff
(100 %id)
BF447885 carcinoid, lung .f-u 853 to 1436 595 to 12   AAA   584/584
(100 %)
0 diff
(100 %id)
BM311731 Pancreas, Purified pancreatic islet .f-u 854 to 1438 585 to 1       585/585
(100 %)
0 diff
(100 %id)
AI093579 uterus .f-u 854 to 1437 584 to 1       584/584
(100 %)
1 diff
(99.9 %id)
DB355982 whole embryo, mainly head .f-u 862 to 1436 569 to 1       569/573
(99 %)
15 diff
(97.4 %id)
FN157842 breast carcinoma .f-u 867 to 967 1 to 101       101/101
(100 %)
2 diff
(98.1 %id)
CB128487 cervix, Uterine .f-u 872 to 1425 1 to 554       554/554
(100 %)
0 diff
(100 %id)
FN105396 breast carcinoma .f-u 872 to 967 1 to 97       97/97
(100 %)
2 diff
(98.0 %id)
TI_159723160   .f-u 878 to 1385 54 to 561     Submitted on the opposite strand 508/1102
(46 %)
1 diff
(100.0 %id)
CB853653 Human Lung Epithelial cells, lung .f-u 878 to 1385 13 to 520     Submitted on the opposite strand 508/529
(96 %)
1 diff
(99.9 %id)
BQ358682 head_neck .f-u 881 to 1268 397 to 1       397/399
(99 %)
30 diff
(92.5 %id)
BF155653 head_neck .f-u 883 to 1259 376 to 1       376/376
(100 %)
1 diff
(99.8 %id)
BF833207 head_neck .f-u 883 to 1195 318 to 5     Submitted on the opposite strand 314/318
(98 %)
0 diff
(100 %id)
BP424360 small intestine .f-u 890 to 1437 1 to 548     Submitted on the opposite strand 548/548
(100 %)
0 diff
(100 %id)
BU687014 lung, Primary Lung Epithelial Cells .f-u 891 to 1436 564 to 19   AAA   546/546
(100 %)
0 diff
(100 %id)
BU681894 lung .f-u 891 to 1436 564 to 19   AAA   546/546
(100 %)
0 diff
(100 %id)
BQ003084 Chondrosarcoma, Left Pelvis .f-u 892 to 1436 563 to 19   AAA   545/545
(100 %)
0 diff
(100 %id)
BM983572 lung .f-u 892 to 1436 563 to 19   AAA   545/545
(100 %)
0 diff
(100 %id)
BM684670 eye, fetal eye .f-u 892 to 1439 566 to 19   AAA   548/548
(100 %)
2 diff
(99.7 %id)
AI309998 2 pooled tumors (clear cell type), Kidney .f-u 893 to 1437 552 to 8       545/552
(98 %)
0 diff
(100 %id)
BM670292 eye, lens .f-u 893 to 1436 562 to 19   AAA   544/544
(100 %)
1 diff
(99.9 %id)
N48863 multiple sclerosis lesions .f-u 895 to 1143 1 to 248       248/249
(99 %)
7 diff
(97.2 %id)
AW971986   .f-u 902 to 1400 76 to 573       498/573
(86 %)
0 diff
(100 %id)
AA482724 alveolar rhabdomyosarcoma .f-u 902 to 1383 8 to 488       481/488
(98 %)
0 diff
(100 %id)
FN125850 breast carcinoma .f-u 907 to 1004 100 to 1     Submitted on the opposite strand 100/103
(97 %)
8 diff
(92.3 %id)
TI_149272305   .f-u 908 to 1439 640 to 110   AAA   531/980
(54 %)
7 diff
(99.3 %id)
AI334147 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .f-u 913 to 1437 528 to 4       525/528
(99 %)
0 diff
(100 %id)
AI660920 colon, colonic mucosa from 5 ulcerative colitispatients .f-u 915 to 1439 540 to 16   AAA   525/525
(100 %)
2 diff
(99.7 %id)
AW778727 colon, moderately-differentiated adenocarcinoma .f-u 915 to 1439 525 to 1       525/525
(100 %)
0 diff
(100 %id)
BU674982 lung, Primary Lung Epithelial Cells .f-u 917 to 1439 541 to 19   AAA   523/531
(98 %)
2 diff
(99.7 %id)
AI377507   .f-u 924 to 1438 518 to 4       515/518
(99 %)
0 diff
(100 %id)
AW148553 brain, tumor, 5 pooled (see description) .f-u 928 to 1436 510 to 1       510/510
(100 %)
2 diff
(99.7 %id)
AI609942 adenocarcinoma, Pancreas .f-u 931 to 1439 509 to 1       509/509
(100 %)
0 diff
(100 %id)
AW074196 2 pooled high-grade transitional celltumors, genitourinary tract .f-u 931 to 1439 521 to 13   AAA   509/509
(100 %)
3 diff
(99.5 %id)
AI023483   .f-u 942 to 1437 498 to 3       496/498
(99 %)
0 diff
(100 %id)
AI948967 2 pooled tumors (clear cell type), Kidney .f-u 943 to 1437 504 to 8       497/504
(98 %)
0 diff
(100 %id)
N92587 parathyroid gland, parathyroid tumor .f-u 946 to 1440 501 to 6       496/502
(98 %)
0 diff
(100 %id)
DB523448 testis .f-u 956 to 1439 1 to 484     Submitted on the opposite strand 484/484
(100 %)
0 diff
(100 %id)
DB355438 whole embryo, mainly head .f-u 956 to 1439 488 to 1       488/527
(92 %)
22 diff
(95.9 %id)
FN133208 breast carcinoma .f-u 962 to 1063 103 to 1     Submitted on the opposite strand 103/104
(99 %)
1 diff
(99.1 %id)
AI828478 adenocarcinoma, Pancreas .f-u 962 to 1437 477 to 1       477/477
(100 %)
1 diff
(99.8 %id)
AI921700 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .f-u 962 to 1439 511 to 33   AAA   479/479
(100 %)
22 diff
(95.5 %id)
BE349001 malignant melanoma, metastatic to lymphnode, skin .f-u 963 to 1436 485 to 12   AAA   474/474
(100 %)
0 diff
(100 %id)
AI624033 adenocarcinoma, Pancreas .f-u 966 to 1437 475 to 4       472/475
(99 %)
0 diff
(100 %id)
AI926565 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .f-u 968 to 1436 484 to 16   AAA   469/469
(100 %)
1 diff
(99.8 %id)
AI953959 brain, three pooled meningiomas .f-u 968 to 1437 478 to 9       470/478
(98 %)
0 diff
(100 %id)
AA931462 Kidney .f-u 970 to 1440 472 to 2   tiling clone,   471/472
(99 %)
0 diff
(100 %id)
AI372898 uterus .f-u 971 to 1437 472 to 6       467/472
(98 %)
0 diff
(100 %id)
AI096659 uterus .f-u 975 to 1436 462 to 1       462/462
(100 %)
4 diff
(99.2 %id)
DB539864 hippocampus .f-u 979 to 1435 1 to 457     Submitted on the opposite strand 457/457
(100 %)
0 diff
(100 %id)
BE301506 cervical carcinoma cell line, cervix .f-u 986 to 1439 474 to 22   AAA   453/453
(100 %)
7 diff
(98.5 %id)
AW262563 brain, three pooled meningiomas .f-u 989 to 1440 436 to 4       433/445
(97 %)
0 diff
(100 %id)
BM021514 Islets of Langerhans, Pancreas .f-u 989 to 1437 1 to 449       449/455
(98 %)
4 diff
(99.2 %id)
AI953758 brain, three pooled meningiomas .f-u 992 to 1436 445 to 1       445/445
(100 %)
0 diff
(100 %id)
FN090180 breast carcinoma .f-u 996 to 1087 93 to 1     Submitted on the opposite strand 93/94
(98 %)
1 diff
(99.0 %id)
DB530453 hippocampus .f-u 997 to 1435 1 to 440     Submitted on the opposite strand 440/440
(100 %)
0 diff
(100 %id)
AI636254 Kidney .f-u 1005 to 1436 447 to 16   AAA   432/432
(100 %)
0 diff
(100 %id)
BQ022993 placenta .f-u 1007 to 1436 448 to 19   AAA   430/430
(100 %)
1 diff
(99.8 %id)
AI167302 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .f-u 1008 to 1436 429 to 1       429/429
(100 %)
1 diff
(99.8 %id)
AA875842 2 pooled tumors (clear cell type), Kidney .f-u 1010 to 1437 435 to 8       428/435
(98 %)
0 diff
(100 %id)
AA706222 parathyroid gland, parathyroid tumor .f-u 1013 to 1437 430 to 6       425/430
(98 %)
0 diff
(100 %id)
BU737765 eye, lens .f-u 1018 to 1436 438 to 19   AAA   420/420
(100 %)
8 diff
(98.1 %id)
AI022130 parathyroid gland, parathyroid tumor .f-u 1019 to 1437 424 to 6       419/424
(98 %)
0 diff
(100 %id)
DB509150 testis .f-u 1022 to 1439 1 to 424     Submitted on the opposite strand 424/424
(100 %)
9 diff
(97.9 %id)
DB533801 hippocampus .f-u 1026 to 1435 1 to 410     Submitted on the opposite strand 410/410
(100 %)
0 diff
(100 %id)
H43621 breast .f-u 1026 to 1415 405 to 1       405/405
(100 %)
17 diff
(95.9 %id)
AI084529   .f-u 1027 to 1309 283 to 1       283/283
(100 %)
0 diff
(100 %id)
AW272306 colon, moderately-differentiated adenocarcinoma .f-u 1027 to 1437 419 to 9       411/419
(98 %)
0 diff
(100 %id)
AW612485 Kidney .f-u 1027 to 1432 410 to 5       406/410
(99 %)
0 diff
(100 %id)
AI264779 adenocarcinoma, Pancreas .f-u 1029 to 1437 410 to 2       409/410
(99 %)
0 diff
(100 %id)
CB138914 Liver .f-u 1029 to 1436 1 to 408   AAA   408/408
(100 %)
0 diff
(100 %id)
CB140017 Liver .f-u 1029 to 1435 1 to 407       407/407
(100 %)
0 diff
(100 %id)
CB137811 Liver .f-u 1029 to 1436 1 to 408   AAA   408/408
(100 %)
0 diff
(100 %id)
CB138635 Liver .f-u 1029 to 1436 1 to 408   AAA   408/408
(100 %)
0 diff
(100 %id)
BQ361907 ovary .f-u 1030 to 1229 219 to 20       200/219
(91 %)
0 diff
(100 %id)
AI801512 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .f-u 1030 to 1439 430 to 21   AAA   410/410
(100 %)
1 diff
(99.8 %id)
CA450049 Human Lung Epithelial cells, lung .f-u 1030 to 1436 424 to 19   AAA   406/415
(97 %)
1 diff
(99.8 %id)
AI285412 esophagus, squamous cell carcinoma .f-u 1031 to 1437 407 to 1       407/407
(100 %)
0 diff
(100 %id)
AI366727 anaplastic oligodendroglioma, brain .f-u 1031 to 1439 429 to 21   AAA   409/409
(100 %)
2 diff
(99.6 %id)
AI362557 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .f-u 1032 to 1436 405 to 1       405/405
(100 %)
0 diff
(100 %id)
R78745 placenta .f-u 1034 to 1415 387 to 1   fully sequenced,   387/387
(100 %)
4 diff
(99.0 %id)
AI274861 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .f-u 1035 to 1436 402 to 1       402/402
(100 %)
0 diff
(100 %id)
AW129100 brain, tumor, 5 pooled (see description) .f-u 1039 to 1436 413 to 16   AAA   398/398
(100 %)
2 diff
(99.5 %id)
AI802793 colon, colonic mucosa from 5 ulcerative colitispatients .f-u 1043 to 1439 416 to 20   AAA   397/397
(100 %)
1 diff
(99.8 %id)
FN130785 breast carcinoma .f-u 1049 to 1166 1 to 115       115/115
(100 %)
3 diff
(97.4 %id)
BE615229 adenocarcinoma, Pancreas .f-u 1049 to 1437 41 to 422       382/424
(90 %)
8 diff
(98.2 %id)
AA962495 2 pooled tumors (clear cell type), Kidney .f-u 1052 to 1439 388 to 1       388/388
(100 %)
0 diff
(100 %id)
AA709042 uterus .f-u 1053 to 1436 398 to 15   AAA   384/384
(100 %)
0 diff
(100 %id)
BM782351 stomach .f-u 1062 to 1436 1 to 375   AAA   375/378
(99 %)
1 diff
(99.8 %id)
BM782434 stomach .f-u 1062 to 1439 1 to 378   AAA   378/378
(100 %)
1 diff
(99.8 %id)
BM740182 stomach .f-u 1062 to 1439 1 to 376   AAA   376/376
(100 %)
3 diff
(99.3 %id)
AW341935 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .f-u 1069 to 1439 382 to 12   AAA   371/371
(100 %)
0 diff
(100 %id)
FN161450 breast carcinoma .f-u 1072 to 1185 114 to 1     Submitted on the opposite strand 114/114
(100 %)
2 diff
(98.3 %id)
AA587812 normal prostate, Prostate .f-u 1073 to 1437 365 to 1       365/365
(100 %)
0 diff
(100 %id)
EC485370 Prostate .f-u 1077 to 1193 1 to 116       116/116
(100 %)
4 diff
(96.6 %id)
N62364 multiple sclerosis lesions .f-u 1078 to 1440 367 to 3       365/368
(99 %)
0 diff
(100 %id)
AI561123 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .f-u 1080 to 1436 378 to 22   AAA   357/357
(100 %)
4 diff
(98.9 %id)
AI351881 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .f-u 1085 to 1436 363 to 12   AAA   352/352
(100 %)
0 diff
(100 %id)
AA214606 germinal center B cell .f-u 1094 to 1436 343 to 1       343/347
(98 %)
0 diff
(100 %id)
AA577932 bone marrow, stem cells .f-u 1100 to 1437 358 to 21       338/358
(94 %)
0 diff
(100 %id)
T90516 lung .f-u 1105 to 1404 308 to 1       308/435
(70 %)
7 diff
(98.4 %id)
TI_149272823   .f-u 1120 to 1436 400 to 84   AAA   317/959
(33 %)
3 diff
(99.7 %id)
BU675345 lung, Primary Lung Epithelial Cells .f-u 1120 to 1436 335 to 19   AAA   317/325
(97 %)
3 diff
(99.1 %id)
AW338987 adenocarcinoma, Pancreas .f-u 1125 to 1437 314 to 2       313/314
(99 %)
0 diff
(100 %id)
BU565125 mixed (pool of 40 RNAs) .f-u 1129 to 1434 1 to 306       306/343
(89 %)
2 diff
(99.5 %id)
BM744763 stomach .f-u 1131 to 1298 1 to 169       169/169
(100 %)
1 diff
(99.5 %id)
AW772513 Kidney .f-u 1138 to 1436 299 to 1       299/299
(100 %)
0 diff
(100 %id)
AW118298 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .f-u 1140 to 1436 298 to 1       298/298
(100 %)
2 diff
(99.4 %id)
AA844346 parathyroid gland, parathyroid tumor .f-u 1150 to 1440 296 to 6       291/296
(98 %)
0 diff
(100 %id)
AI333670 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .f-u 1151 to 1436 315 to 30   AAA   286/286
(100 %)
8 diff
(97.3 %id)
CN280804 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .f-u 1175 to 1436 8 to 268   AAA   261/268
(97 %)
0 diff
(100 %id)
BU742606 eye, fetal eye .f-u 1177 to 1436 278 to 19   AAA   260/260
(100 %)
0 diff
(100 %id)
AA908453 ovary, serous adenocarcinoma .f-u 1196 to 1436 241 to 1       241/241
(100 %)
0 diff
(100 %id)
AA873144 2 pooled tumors (clear cell type), Kidney .f-u 1196 to 1437 245 to 4       242/245
(98 %)
0 diff
(100 %id)
FN048945 breast carcinoma .f-u 1198 to 1271 1 to 74       74/75
(98 %)
1 diff
(98.7 %id)
AI784678 uterus .f-u 1209 to 1436 227 to 1       227/227
(100 %)
1 diff
(99.6 %id)
N89811 parathyroid gland, parathyroid tumor .f-u 1212 to 1436 225 to 1       225/234
(96 %)
0 diff
(100 %id)
BQ022494 placenta .f-u 1225 to 1436 229 to 18   AAA   212/212
(100 %)
1 diff
(99.6 %id)
BG108747 retina, Retinal Pigment Epithelium sheets .f-u 1227 to 1430 1 to 205       205/205
(100 %)
1 diff
(99.6 %id)
AW582807   .f-u 1229 to 1423 195 to 1       195/197
(98 %)
1 diff
(99.5 %id)
AW582808   .f-u 1229 to 1423 198 to 1       198/199
(99 %)
2 diff
(99.0 %id)
FN087788 breast carcinoma .f-u 1229 to 1336 1 to 103       103/103
(100 %)
5 diff
(95.2 %id)
AI702361 adenocarcinoma, Pancreas .f-u 1229 to 1436 218 to 11   AAA   208/208
(100 %)
0 diff
(100 %id)
AA890314 parathyroid gland, parathyroid tumor .f-u 1231 to 1437 212 to 6       207/212
(97 %)
0 diff
(100 %id)
BF351510 head_neck .f-u 1233 to 1438 221 to 10       212/221
(95 %)
0 diff
(100 %id)
AW582805   .f-u 1245 to 1373 130 to 1       130/130
(100 %)
1 diff
(99.3 %id)
FN097383 breast carcinoma .f-u 1277 to 1384 104 to 1     Submitted on the opposite strand 104/107
(97 %)
7 diff
(93.5 %id)
CK823162 Islets of Langerhans, Pancreas .f-u 1277 to 1438 162 to 1       162/173
(93 %)
0 diff
(100 %id)
BQ101180 Islets of Langerhans, Pancreas .f-u 1278 to 1441 1 to 164       164/184
(89 %)
1 diff
(99.5 %id)
BQ101131 Islets of Langerhans, Pancreas .f-u 1278 to 1441 1 to 164   tiling clone,   164/184
(89 %)
1 diff
(99.5 %id)
CB109849 Liver .f-u 1282 to 1440 1 to 159       159/178
(89 %)
1 diff
(99.5 %id)
AW582823   .f-u 1294 to 1418 128 to 1       128/129
(99 %)
4 diff
(96.9 %id)
AW469437 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .f-u 1306 to 1437 135 to 4       132/135
(97 %)
0 diff
(100 %id)
AA044639 uterus .f-u 1314 to 1437 124 to 1       124/124
(100 %)
0 diff
(100 %id)
AA910668 Kidney .f-u 1365 to 1436 85 to 14   AAA   72/72
(100 %)
0 diff
(100 %id)
FN072963 breast carcinoma .f-u 1369 to 1431 63 to 1     Submitted on the opposite strand 63/64
(98 %)
0 diff
(100 %id)
AW994206 breast_normal .g-u 1 to 638 7 to 649 M2D C12A L14F Q15K D16M ... tiling clone,   643/661
(97 %)
16 diff
(97.6 %id)
BE813414 breast_normal .g-u 24 to 349 1 to 332   tiling clone,   332/332
(100 %)
15 diff
(95.5 %id)
AA320843 adipose tissue, white .g-u 610 to 813 1 to 204   tiling clone,   204/204
(100 %)
0 diff
(100 %id)
BQ292400 amnion_normal .h-u 1 to 510 14 to 524 exact tiling clone,   511/524
(97 %)
0 diff
(100 %id)
DW429827 Liver .i-u 1 to 380 17 to 396 exact tiling clone,   380/396
(95 %)
0 diff
(100 %id)
N83286   .j 1 to 321 1 to 320 N28T C29A T30L S31Q D32I ... tiling clone,   320/320
(100 %)
4 diff
(98.8 %id)
AV682381 hepatocellular carcinoma Gene ITGAV, variant not shown         Suspected internal deletion, this clone was ignored    
AV681773 hepatocellular carcinoma Gene ITGAV, variant not shown         Suspected internal deletion, this clone was ignored    
AV689443 hepatocellular carcinoma Gene ITGAV, variant not shown         This clone was ignored    
AV691497 hepatocellular carcinoma Gene ITGAV, variant not shown         Suspected internal deletion, this clone was ignored    
AV700523 hepatocellular carcinoma Gene ITGAV, variant not shown         Suspected internal deletion, this clone was ignored    
AV694569 hepatocellular carcinoma Gene ITGAV, variant not shown         Suspected internal deletion, this clone was ignored    
AK302550 testis Gene ITGAV, variant not shown         This clone was ignored    
TI_2194647009   Gene ITGAV, variant not shown         This clone was ignored    
BU189592 melanotic melanoma, skin Gene ITGAV, variant not shown              
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f-u, .g-u, .h-u, .i-u, .j Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI